RPT-AstraZeneca's Farxiga fails to get FDA approval for Type-1 diabetes
July 15, 2019 at 02:31 AM EDT
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with Type-1 diabetes.